Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First quarter Ended March 31, 2021
April 27, 2021 at 06:50 am EDT
Share
Beijing Leadman Biochemistry Co.,Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 115.723 million compared to CNY 55.831 million a year ago. Operating income was CNY 13.296 million compared to operating loss of CNY 12.669 million a year ago. Net income was CNY 6.269 million compared to net loss of CNY 15.472 million a year ago. Basic earnings per share from continuing operations was CNY 0.015 compared to basic loss per share from continuing operations of CNY 0.037 a year ago.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. 
